Tag Archives: pharmaceutical

Medisafe Increasing Pharma Partnerships

Digital therapeutic and pharmaceutical companies continue to determine how to integrate their resources to collaborate successfully

Vizient Launches Next Generation eCommerce Exchange

Vizient Launches Next Generation eCommerce Exchange Growing trends in group healthcare group purchasing/procurement include hospitals and health systems creating new supply chain management organizations and new market entrants developing procurement platforms to make purchasing of healthcare and pharmaceutical products easier and more cost-efficient. Vizient, Inc., the largest member-driven health care performance improvement company in the […]

Medical Jargon, Acronyms that Most Confuse Patients

The utilization of acronyms, jargon and common medical terms will continue within the healthcare industry. And like it or not, new terms will be introduced. The key for the entire industry is to encourage the use of clear language when communicating with non-clinician colleagues as well as with members

Value-Based Contracting in Commercial Insurance

Background on risk-sharing and insight into risk-sharing agreements from a payer’s and manufacturer’s perspective.

Outcome-Based Contracting Acceptance Grows in Market

Specialty Pharma Services

Outcome-Based Contracting Acceptance Grows in market with the concept of taking on financial risk on complex contracts as a result of market pressure combined with more familiarity. Outcome-based contracts between pharma companies and health insurers are becoming increasingly popular. In 2016, Novartis, Amgen, and Sanofi publicized risk-sharing, value-based, outcomes-based, or pay-for-performance deals, all of which vary […]

Managed care pharmacy survey findings 2016

Managed care pharmacy survey findings 2016 Managed Healthcare Executive September 26, 2016 To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, conducted its first-ever pharmacy survey during the second quarter of 2016. […]

Future of Specialty Pharmacy and More

Future of Specialty Pharmacy – Recent events involving Valeant and Philidor have caused an uproar in the marketplace along with the Turing Pharmaceutical (and generics) mess around pricing. Now the NY Times casts the light on Horizon and Linden illustrating the bad without much good around stakeholder relationships that pharma firms have utilized. Due to the evolution […]

John Santilli quoted in Modern Medicine: FDA approves Cyramza in combination with paclitaxel for advanced gastric cancer after prior chemotherapy

“Cyramza, approved earlier this year for stomach cancer, is a key product in Lilly’s oncology portfolio,” said John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries. “With the colorectal cancer market becoming increasingly crowded, Lilly will need to review the pricing strategy for Cyramza to make sure the drug remains competitive […]